1 / 29

Module 4

Module 4. HIV Infection in Women. HIV Infection in Women. Garrett Colmorgen, MD, Director Maternal Fetal Medicine, Christiana Care Health Services, Wilmington, Delaware

alika-tillman
Télécharger la présentation

Module 4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Module 4 HIV Infection in Women

  2. HIV Infection in Women • Garrett Colmorgen, MD, Director Maternal Fetal Medicine, Christiana Care Health Services, Wilmington, Delaware • Staff of the Pennsylvania/Mid-Atlantic AIDS Education & Training Center, Delaware Local Performance Site - P. Lincoln, N. Bennett, M.A. Bartkowski

  3. Demographics of HIV in Women • Fastest growing group in the United States • 4th leading cause of death aged 25 to 44 in the United States • Disproportionately affects African Americans & Hispanics living on the eastern seaboard CDC-2000

  4. Statistics of HIV in Women • Cumulative Statistics as of December 2000 in the United States • 74,997 African American • 28, 151 White • 25,643 Hispanic • 1,133 Other • Total 130, 104 CDC 2000

  5. HIV Transmission Risk Behaviors for Women • Heterosexual - 62% • African American - 63% • White - 18% • Hispanic - 18% • Other - 1% • primary risk behavior for all age groups of women • IVDU - 35% • Other - 3% CDC 2000

  6. Female Condom • “Reality” - only brand currently marketed in the US • Made of polyurethane, sheath closed at one end with flexible rings at both ends Anderson, J. 2001

  7. Microbicides • Strategy enabling women to have control over safer sex/prevention of HIV • Nonoxynol-9 increases risk of HIV infection • Clinical trials of topical microbicides are being conducted Anderson, J. 2001

  8. Gender Bias Transmission • More efficient from man to woman than woman to man • Related to number of infectious particles in body fluid • Related to volume of fluids exchanged • Related to surface area coming in contact with infected body fluid HRSA:BPHC & AETC

  9. Risk Factors for Male to Female HIV Transmission • Anal Intercourse • Lack of male circumcision • Genital ulcers (syphilis, herpes simplex, chancroid) • Sexually Transmitted Diseases • Multiple sexual partners

  10. Special Consideration • Early Adolescent • immaturity of the female genital track increases risk of transmission • Women over 50 years of age • atrophic vaginitis caused by decreased lubrication • older females are generally not perceived to be at risk

  11. Natural History of HIV Disease in Women • Same as in men except for GYN symptoms and disease conditions • 1993 CDC added invasive cervical cancer as an AIDS defining condition • Women are often diagnosed late • Women may have barriers to care HRSA:BPHC & AETC

  12. Challenges in Caring for Women with HIV • Statistically economically poorer than men • More likely to be single parents • lack of child care • lack of support • More likely to be uninsured HRSA:BPHC & AETC

  13. Signs and Symptoms of HIV in Women • Acute Seroconversion - (No distinct gender differences however many of these s&s often go under addressed) • fever • swollen glands Bartlett, J. 1999

  14. Signs and Symptoms of HIV in Women cont’ • Rash - macular or maculopapular, usually nonpururitic. Truncal / facial distribution can involve arms and legs. Often appears several days past onset of fever. • Fatigue • Mono-spot test is negative • Bartlett, J. 1999

  15. HIV-Related Gynecological Conditions • Vaginal candidiasis • Human Papilloma Virus • Genital Ulcers • Pelvic Inflammatory Disease • Cervical Dysplasia/Neoplasia • Menstrual Disturbances HRSA:BPHC & AETC

  16. Diagnostic Studies • Pap smear • two studies the first year of diagnosis • annually if normal • recommended every 6 months if HIV is symptomatic • Colposcopy USPHS/IDSA 2001

  17. Prenatal & Family Planning HIV Screening • DHHS guidelines suggest universal HIV testing with patient notification as a routine component of prenatal care • Pre and post test counseling & informed consent - laws vary by state USPHS/IDSA 2001

  18. Pregnancy • Does not appear to accelerate HIV infection

  19. Perinatal HIV Transmission May Occur • Antepartum • during pregnancy • Intrapartum • during labor • during delivery • Postpartum-through breast feeding HRSA:BPHC & AETC

  20. Reducing Perinatal Transmission • ACTG 076 • women given AZT after first trimester • AZT administered intravenously during labor • newborn receives AZT for 6 weeks • transmission reduced by 67.5% • Combination therapy has reduced the rate even further HRSA:BPHC & AETC

  21. Antepartum/Intrapartum Management Considerations • Avoid amniocentesis • Avoid premature rupture of membranes • Avoid fetal scalp monitoring • Delay episiotomy HRSA:BPHC & AETC

  22. HIV Medications to avoid during Pregnancy • Efavirenz - associated with anencephaly, anopthalmia Neural tube defects in primates • Indinavir - Potential for nephrolithiasis and neonatal hyperbilirubinemia DeLorenzo, L. 2001

  23. HIV Medications to avoid during Pregnancy, cont’ • Didanosine/Stavudine - combination associated with fatal lactic acidosis in pregnancy • Stavudine/Retrovir -combination is antagonistic, decreasing efficacy of therapy DeLorenzo, L. 2001

  24. Antiretroviral Pregnancy Registry • Collaborative effort between the CDC, NIH and pharmaceutical companies to monitor for birth defects in infants exposed to antiretroviral agents • antiretroviral exposure during pregnancy should be reported to the registry at 1-800-258-4263 Anderson, J. 2001

  25. Current Prevention Message-Is it Reality ? • Abstinence • Monogamy • Reduce number of partners • Ask partner about history of infection • Enforce use of condoms Colmorgen, G. 1999

  26. References • Anderson, J. (Ed.) (2001). A guide to the clinical care of women with HIV. Rockville, MD: HIV/AIDS Bureau, Health Resources and Services Administration. [Available on-line: http://www.hab.hrsa.gov/publications.html]. • Bartlett, J. & Gallant, J. (2001). 2001-2002 Medical Management of HIV Infection. [Available on-line: http;//hopkins-aids.edu

  27. References, cont’ • Center for Disease Control and Prevention. (2002,February). Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. [Available on-line: http://www.hivatis.org.]

  28. References, cont’ • DeLorenzo, L. (2001). Clinical Nursing Series. Nursing Care of the HIV-Infected Patient. Fourth Edition.Western Schools Press.

More Related